{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T04:49:32Z","timestamp":1795063772434,"version":"4.10.2"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.euroneuro.2021.08.264","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T07:58:55Z","timestamp":1630655935000},"page":"75-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"special_numbering":"C","title":["Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5558-2381","authenticated-orcid":false,"given":"Anastasiya","family":"Nestsiarovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.S.","family":"Gaudiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross J.","family":"Baldessarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0548-0053","authenticated-orcid":false,"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiliang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Tohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.euroneuro.2021.08.264_bib0001","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41380-018-0044-2","article-title":"Pharmacological treatment of adult bipolar disorder","volume":"24","author":"Baldessarini","year":"2019","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.08.264_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40345-019-0160-1","article-title":"Bipolar depression: a major unsolved challenge","volume":"8","author":"Baldessarini","year":"2020","journal-title":"Int. J. Bipolar Disord."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.08.264_bib0003","doi-asserted-by":"crossref","first-page":"45","DOI":"10.17712\/nsj.2019.1.20180008","article-title":"Clinical characteristics of antidepressant use and related manic switch in bipolar disorder","volume":"24","author":"Berkol","year":"2019","journal-title":"Neurosciences"},{"issue":"3","key":"10.1016\/j.euroneuro.2021.08.264_bib0004","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jad.2012.01.047","article-title":"A randomized, placebo- and active-controlled study of paliperidone extended-release as maintenance treatment in patients with bipolar i disorder after an acute manic or mixed episode","volume":"138","author":"Berwaerts","year":"2012","journal-title":"J. Affect. Disord."},{"issue":"1\u20132","key":"10.1016\/j.euroneuro.2021.08.264_bib0005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jad.2012.04.024","article-title":"Characterizing relapse prevention in bipolar disorder with adjunctive ziprasidone: clinical and methodological implications","volume":"144","author":"Bowden","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.euroneuro.2021.08.264_bib0006","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4088\/JCP.09m05482yel","article-title":"Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial","volume":"71","author":"Bowden","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2021.08.264_bib50","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archpsyc.60.4.392","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder","volume":"60","author":"Bowden","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"10.1016\/j.euroneuro.2021.08.264_bib62","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1600-0447.2012.01890.x","article-title":"Lamotrigine vs. lamotrigine plus divalproex in randomized, placebo-controlled maintenance treatment for bipolar depression","volume":"126","author":"Bowden","year":"2012","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"10.1016\/j.euroneuro.2021.08.264_bib0007","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archpsyc.57.5.481","article-title":"A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. divalproex maintenance study group","volume":"57","author":"Bowden","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2021.08.264_bib0008","article-title":"Lithium for maintenance treatment of mood disorders","author":"Burgess","year":"2001","journal-title":"Cochrane Database Syst. Rev."},{"issue":"9","key":"10.1016\/j.euroneuro.2021.08.264_bib51","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder","volume":"64","author":"Calabrese","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"10.1016\/j.euroneuro.2021.08.264_bib66","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.euroneuro.2017.06.013","article-title":"Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder","volume":"27","author":"Calabrese","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"issue":"227","key":"10.1016\/j.euroneuro.2021.08.264_bib58","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jad.2017.10.035","article-title":"Symptoms and functioning with aripiprazole once-monthly injection as maintenance treatment for bipolar I disorder","author":"Calabrese","year":"2018","journal-title":"J Affect Disord"},{"issue":"9","key":"10.1016\/j.euroneuro.2021.08.264_bib0009","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.euroneuro.2017.06.013","article-title":"Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder","volume":"27","author":"Calabrese","year":"2017","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol."},{"issue":"11","key":"10.1016\/j.euroneuro.2021.08.264_bib0010","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4088\/JCP.v61n1106","article-title":"A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 study group","volume":"61","author":"Calabrese","year":"2000","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.08.264_bib0011","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1399-5618.2011.00974.x","article-title":"Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392)","volume":"14","author":"Carlson","year":"2012","journal-title":"Bipolar Disord."},{"issue":"12","key":"10.1016\/j.euroneuro.2021.08.264_bib0012","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1177\/0269881109106900","article-title":"Olanzapine in the long-term treatment of bipolar disorder: a systematic review and meta-analysis","volume":"24","author":"Cipriani","year":"2010","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.08.264_bib0013","article-title":"Olanzapine in long-term treatment for bipolar disorder","author":"Cipriani","year":"2009","journal-title":"Cochrane Datab. Syst. Rev."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.08.264_bib0014","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/bdi.12612","article-title":"Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis","volume":"20","author":"Fornaro","year":"2018","journal-title":"Bipolar Disord."},{"issue":"2","key":"10.1016\/j.euroneuro.2021.08.264_bib0015","first-page":"121","article-title":"The international college of neuro-psychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 2: review, grading of the evidence, and a precise algorithm","volume":"20","author":"Fountoulakis","year":"2017","journal-title":"Int. J. Neuropsychopharmacol. \/ Off. Sci. J. Collegium Int. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.euroneuro.2021.08.264_bib0016","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.161.2.217","article-title":"Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials","volume":"161","author":"Geddes","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.08.264_bib0017","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m13136","article-title":"Citalopram for acute and preventive efficacy in bipolar depression (CAPE-BD): a randomized, double-blind, placebo-controlled trial","volume":"82","author":"Ghaemi","year":"2021","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.08.264_bib0018","article-title":"IBM SPSS statistics for windows, version 19.0. Armonk","year":"2010","journal-title":"NY: IBM Corp"},{"issue":"9","key":"10.1016\/j.euroneuro.2021.08.264_bib0019","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archpsyc.1982.04290090053011","article-title":"Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison","volume":"39","author":"Kane","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.08.264_bib0020","first-page":"144","article-title":"Prophylactic lithium with and without imipramine for bipolar I patients: a double-blind study [proceedings]","volume":"17","author":"Kane","year":"1981","journal-title":"Psychopharmacol. Bull."},{"issue":"10","key":"10.1016\/j.euroneuro.2021.08.264_bib53","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4088\/JCP.v68n1003","article-title":"Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo","volume":"68","author":"Keck","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.08.264_bib0021","article-title":"Mood stabilizers and\/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials","author":"Kishi","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.08.264_bib0022","first-page":"1","article-title":"Recurrence rates in stable bipolar disorder patients after drug discontinuation v. drug maintenance: a systematic review and meta-analysis","author":"Kishi","year":"2020","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2021.08.264_bib0023","author":"Kishi","year":"2021","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2021.08.264_bib0024","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2021.08.264_bib0025","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jad.2017.02.012","article-title":"Maintenance therapy with second generation antipsychotics for bipolar disorder - a systematic review and meta-analysis","volume":"213","author":"Lindstr\u00f6m","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2021.08.264_bib0026","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jad.2017.07.023","article-title":"Efficacy and safety of long-term antidepressant treatment for bipolar disorders - a meta-analysis of randomized controlled trials","volume":"223","author":"Liu","year":"2017","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.08.264_bib0027","article-title":"Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder","author":"Macritchie","year":"2001","journal-title":"Cochrane Datab. Syst. Rev."},{"issue":"4","key":"10.1016\/j.euroneuro.2021.08.264_bib0028","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1176\/appi.ajp.2007.07121846","article-title":"Bipolar disorders and recurrent depression, second edition","volume":"165","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.08.264_bib0030","article-title":"A 52-week prophylactic randomised control trial of omega-3 polyunsaturated fatty acids in bipolar disorder","author":"McPhilemy","year":"2020","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2021.08.264_bib0031","article-title":"Adjunctive psychotherapy for bipolar disorder a systematic review and component network meta-analysis","author":"Miklowitz","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.euroneuro.2021.08.264_bib0032","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S2215-0366(14)70314-1","article-title":"Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis","volume":"1","author":"Miura","year":"2014","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2021.08.264_bib0033","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/npr2.12056","article-title":"Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials with an enrichment design","volume":"39","author":"Oya","year":"2019","journal-title":"Neuropsychopharmacol. Rep."},{"issue":"2","key":"10.1016\/j.euroneuro.2021.08.264_bib0034","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/104454603322163880","article-title":"Switching, cycling, and antidepressant-induced effects on cycle frequency and course of illness in adult bipolar disorder: a brief review and commentary","volume":"13","author":"Papolos","year":"2003","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.euroneuro.2021.08.264_bib0035","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/YIC.0000000000000097","article-title":"Prophylactic efficacy of lithium, valproic acid, and carbamazepine in the maintenance phase of bipolar disorder: a naturalistic study","volume":"31","author":"Peselow","year":"2016","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.euroneuro.2021.08.264_bib0036","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.euroneuro.2011.09.008","article-title":"Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder","volume":"22","author":"Popovic","year":"2012","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol."},{"issue":"11","key":"10.1016\/j.euroneuro.2021.08.264_bib0037","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1001\/archpsyc.1983.01790220086014","article-title":"Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH collaborative study group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination","volume":"41","author":"Prien","year":"1984","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2021.08.264_bib54","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.biopsych.2010.01.015","article-title":"Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder","volume":"68","author":"Quiroz","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"8","key":"10.1016\/j.euroneuro.2021.08.264_bib0038","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/archpsyc.1981.01780330060006","article-title":"Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. A double-blind study","volume":"38","author":"Quitkin","year":"1981","journal-title":"Arch. Gen. Psychiatry"},{"issue":"7","key":"10.1016\/j.euroneuro.2021.08.264_bib0039","doi-asserted-by":"crossref","first-page":"675","DOI":"10.4088\/JCP.12r08046","article-title":"Lamotrigine in psychiatric disorders","volume":"74","author":"Reid","year":"2013","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2021.08.264_bib57","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/15622975.2012.665177","article-title":"A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder","volume":"15","author":"Young","year":"2014","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.08.264_bib0040","unstructured":"\u201cRevMan.\u201d n.d. Accessed October 12, 2020. https:\/\/training.cochrane.org\/online-learning\/core-software-cochrane-reviews\/revman."},{"key":"10.1016\/j.euroneuro.2021.08.264_bib0041","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40345-014-0015-8","article-title":"Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis","volume":"2","author":"Severus","year":"2014","journal-title":"Int. J. Bipolar Disord."},{"issue":"5","key":"10.1016\/j.euroneuro.2021.08.264_bib0042","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1017\/S1092852916000523","article-title":"Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials","volume":"21","author":"Solmi","year":"2016","journal-title":"CNS Spectr."},{"key":"10.1016\/j.euroneuro.2021.08.264_bib0043","article-title":"Release 13. Statistical software.\u201d StataCorp LP","author":"Stata","year":"2013","journal-title":"College Station, TX"},{"issue":"4","key":"10.1016\/j.euroneuro.2021.08.264_bib61","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1176\/appi.ajp.2008.08020189","article-title":"Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127)","volume":"166","author":"Suppes","year":"2009","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.08.264_bib0044","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1176\/appi.ajp.2017.16040419","article-title":"Randomized, double-blind, placebo-controlled trial of asenapine maintenance therapy in adults with an acute manic or mixed episode associated with bipolar I disorder","volume":"175","author":"Szegedi","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"184","key":"10.1016\/j.euroneuro.2021.08.264_bib59","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1192\/bjp.184.4.337","article-title":"Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone","author":"Tohen","year":"2004","journal-title":"Br J Psychiatry"},{"issue":"7","key":"10.1016\/j.euroneuro.2021.08.264_bib64","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1176\/appi.ajp.162.7.1281","article-title":"Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial","volume":"162","author":"Tohen","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2021.08.264_bib52","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1176\/appi.ajp.163.2.247","article-title":"Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine","volume":"163","author":"Tohen","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"10","key":"10.1016\/j.euroneuro.2021.08.264_bib0045","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.4088\/JCP.v68n1002","article-title":"Self-reported history of manic\/hypomanic switch associated with antidepressant use: data from the systematic treatment enhancement program for bipolar disorder (STEP-BD)","volume":"68","author":"Truman","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2021.08.264_bib60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jad.2008.06.001","article-title":"Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126)","volume":"109","author":"Vieta","year":"2008","journal-title":"J Affect Disord"},{"issue":"8","key":"10.1016\/j.euroneuro.2021.08.264_bib0046","first-page":"1029","article-title":"Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials","volume":"14","author":"Vieta","year":"2011","journal-title":"Int. J. Neuropsychopharmacol. \/ Off. Sci. J. Collegium Int. Neuropsychopharmacol."},{"issue":"11","key":"10.1016\/j.euroneuro.2021.08.264_bib0047","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.euroneuro.2012.03.004","article-title":"A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder","volume":"22","author":"Vieta","year":"2012","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol."},{"issue":"11","key":"10.1016\/j.euroneuro.2021.08.264_bib55","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.4088\/JCP.11m06878","article-title":"Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study)","volume":"72","author":"Weisler","year":"2011","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"10.1016\/j.euroneuro.2021.08.264_bib49","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/hup.1240","article-title":"Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial","volume":"26","author":"Woo","year":"2011","journal-title":"Human Psychopharmacology"},{"issue":"8","key":"10.1016\/j.euroneuro.2021.08.264_bib63","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/mp.2015.158","article-title":"Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial","volume":"21","author":"Yatham","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.08.264_bib0048","series-title":"The Bipolar Book: History, Neurobiology, and Treatment","year":"2015"},{"key":"10.1016\/j.euroneuro.2021.08.264_bib65","unstructured":"2012. Lamotrigine Phase III Study in Bipolar I Disorder. (Accessed 28 August 2021)."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X21007392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X21007392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T18:02:19Z","timestamp":1760378539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X21007392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":64,"alternative-id":["S0924977X21007392"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2021.08.264","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2021.08.264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}